Date: 2015-04-09
Type of information: Nomination
Compound:
Company: MyCartis
Therapeutic area: Diagnostic - Cancer - Oncology
Type agreement:
Action mechanism:
Disease:
Details: * On April 9, 2015, MyCartis announced that Dr. Jan Groen, an accomplished diagnostics executive, was elected to the company’s Board of Directors. Dr. Groen currently serves as president and chief executive officer of MDxHealth, a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer. With his appointment, the size of MyCartis’ Board increases to 7 members. Prior to joining MDxHealth in 2010, Dr. Groen was president and chief operating officer of Agendia, Inc., a privately held, leading molecular diagnostics company that develops and markets genomic diagnostic products a genomic disease management company From 1991 until 1993, Dr. Groen was vice president of Focus Diagnostics Inc., a clinical diagnostic company that was acquired by Quest Diagnostics in 2006. He has been a member of the IBL Internationals Board, an in vitro diagnostic company acquired by Tecan in 2014.
Financial terms:
Latest news:
